Radioimmunodiagnosis of lymph node metastases in head and neck cancer

Oral Diseases

Volumn 9, Issue 5, 2003, Pages 241-248

  De Bree, Remco ^a   Roos, J C ^a   Verel, I ^a   Van Dongen, G A M S ^a   Snow, G B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Head and neck cancer; Lymph node metastases; Monoclonal antibodies; Radioimmunodiagnosis; Squamous cell carcinoma

Indexed keywords

GADOLINIUM PENTETATE; IOPROMIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY E48; MONOCLONAL ANTOBODY U36; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEAD CANCER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSCINTIGRAPHY; INJECTION; LYMPH NODE METASTASIS; NECK CANCER; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; SCINTILLATION CAMERA;

ANTIBODIES, NEOPLASM; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; PALPATION; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0042365173     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2003.02864.x     Document Type: Article

References (21)

1. Adamietz IA, Baum RP, Schemman F et al (1996). Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT. J Nucl Med 37: 1942-1946.
2. Ali S, Tiwari RM, Snow GB (1985). False positive and false negative neck nodes. Head Neck Surg 8: 78-82.
3. Baum RP, Adams S, Kiefer J et al (1993). A novel Technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT. Acta Oncol 32: 747-751.
4. De Bree R, Roos JC, Quak JJ et al (1994a). Clinical screening of monoclonal antibodies 323/A3, cSF-25, and K928 for suitability of targeting tumors in the upper-aerodigestive and respiratory tract. Nucl Med Commun 15: 613-627.
5. 2. J Nucl Med 35: 775-783.
6. 99mTc-labeled monoclonal antibody U36 and its biodistribution in patients with head and neck cancer. Clin Cancer Res 1: 591-598.
7. De Bree R, Kuik J, Quak JJ et al (1998). The impact of tumor volume and other characteristics on uptake of monoclonal antibodies in tumor tissue of head and neck cancer patients. Eur J Nucl Med 25: 1562-1565.
8. De Rossi G, Maurizi M, Almadori G et al (1997). The contribution of immunoscintigraphy to the diagnosis of head and neck tumors. Nucl Med Commun 18: 10-16.
9. Heissler E, Grünert B, Barzen G et al (1994). Radioimmunoscintigraphy of squamous cell carcinoma in the head and neck region. Int J Oral Maxillofac Surg 23: 149-152.
10. Kairemo KJA (1993). Positron emission tomography of monoclonal antibodies. Acta Oncol 32: 825-830.
11. Kau RJ, Alexiou C, Laubenbacher C et al (1999). Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 125: 1322-1328.
12. Larson SM, Pentlow KS, Volkow ND et al (1992). PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med 33: 2020-2023.
13. Leemans CR, Tiwari RM, Nauta JJP et al (1993). Regional lymph node involvement and its significance in the development of distant metastases in head and neck cancer. Cancer 71: 452-456.
14. Meijs WE, Herscheid JDM, Haisma HJ et al (1994). Production of highly pure no-carrier-added zirconium-89 for the labelling of antibodies with a positron emitter. Appl Radiat Isot 45: 1143-1147.
15. Quak JJ, Van Dongen GAMS, Balm AJM et al (1990). A 22-kDa surface antigen detected by monoclonal antibody E48 is exclusively expressed in stratified squamous and transitional epithelia. Am J Pathol 136: 191-197.
16. Schrijvers AHGJ, Quak JJ, Uyterlinde AM et al (1993). MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck. Cancer Res 53: 4383-4390.
17. Shah JP, Strong E, Vikram B (1981). Neck dissection: current status and future possibilities. Clin Bulletin 11: 25-33.
18. Van den Brekel MWM, Stel HV, Castelijns JA et al (1990). Cervical lymph node metastases: assessment of radiologic criteria. Radiology 177: 379-384.
19. Van den Brekel MWM, Castelijns JA, Stel HV et al (1993). Modern imaging techniques and ultrasound guided aspiration cytology for the assessment of the neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 250: 11-17.
20. Verel I, Visser GWM, Boellaard R et al (2002). A novel method for labelling of monoclonal antibodies with the ling-living positron emitter Zirconium-89 for sensitive tumor detection by PET. J Nucl Med in press.
21. Wilson CB, Snook DE, Dhokia B et al (1991). Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124-iodine in patients with breast cancer. Int J Cancer 47: 344-347.